Acute Treatment of Migraine

被引：34

作者：

Tepper, Stewart J. ^{[1
]}

Spears, Roderick C. ^{[1
]}

机构：

[1] Cleveland Clin, Ctr Headache & Pain, Cleveland, OH 44195 USA

来源：

NEUROLOGIC CLINICS | 2009年 / 27卷 / 02期

关键词：

Migraine; Acute treatment; Triptans; Ergots; Rebound; Rescue; DOUBLE-BLIND; CARE STRATEGIES; TOLFENAMIC ACID; HEADACHE; PLACEBO; PAIN; ACETAMINOPHEN; COMBINATION; RECURRENCE; TRIPTANS;

D O I：

10.1016/j.ncl.2008.11.008

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

100204 [神经病学];

摘要：

The goals of acute treatment of migraine are cost-effective rapid relief, consistent reduction of disability, and reduced use of rescue medications. Key to acute treatment is matching medication to disability as a surrogate marker for disease severity with a stratified care approach. In the absence of vascular contraindications, triptans are first-line acute treatments for disabling migraine. Acute treatment success can be assessed with use of the paper tool, Migraine-ACT. Opioids and butalbital should be avoided in acute migraine treatment. Triptan type can be selected for patients by differences in speed or effect, formulation, and formulary tier.

引用

页码：417 / +

页数：12

共 37 条

[1]

Acute migraine medications and evolution from episodic to chronic migraine: A longitudinal population-based study [J].

Bigal, Marcelo E. ;

Serrano, Daniel ;

Buse, Dawn ;

Scher, Ann ;

Stewart, Walter F. ;

Lipton, Richard B. .

HEADACHE, 2008, 48 (08) :1157-1168

[2]

Ergotamine and dihydroergotamine: A review [J].

Marcelo E. Bigal ;

Stewart J. Tepper .

Current Pain and Headache Reports, 2003, 7 (1) :55-62

[3]

Transformed migraine and medication overuse in a tertiary headache centre - clinical characteristics and treatment outcomes [J].

Bigal, ME ;

Rapoport, AM ;

Sheftell, FD ;

Tepper, SJ ;

Lipton, RB .

CEPHALALGIA, 2004, 24 (06) :483-490

[4]

DOUBLE-BLIND COMPARISON OF AN ACETAMINOPHEN 400 MG CODEINE 25 MG COMBINATION VERSUS ASPIRIN 1000 MG AND PLACEBO IN ACUTE MIGRAINE ATTACK [J].

BOUREAU, F ;

JOUBERT, JM ;

LASSERRE, V ;

PRUM, B ;

DELECOEUILLERIE, G .

CEPHALALGIA, 1994, 14 (02) :156-161

[5]

Sumatriptan-naproxen for acute treatment of migraine - A randomized trial [J].

Brandes, Jan Lewis ;

Kudrow, David ;

Stark, Stuart R. ;

O'Carroll, C. Phillip ;

Adelman, James U. ;

O'Donnell, Francis J. ;

Alexander, W. James ;

Spruill, Susan E. ;

Barrett, Pamela S. ;

Lener, Shelly E. .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 297 (13) :1443-1454

[6]

Defeating migraine pain with triptans: A race against the development of cutaneous allodynia [J].

Burstein, R ;

Collins, B ;

Jakubowski, M .

ANNALS OF NEUROLOGY, 2004, 55 (01) :19-26

[7]

Analgesic triptan action in an animal model of intracranial pain: A race against the development of central sensitization [J].

Burstein, R ;

Jakubowski, M .

ANNALS OF NEUROLOGY, 2004, 55 (01) :27-36

[8]

CARASSO RL, 1984, BRIT J CLIN PRACT, V38, P25

[9]

Introduction: Cardiovascular safety and triptans in the acute treatment of migraine [J].

Dodick, DW .

HEADACHE, 2004, 44 :S1-S4

[10]

Identifying patients who require a change in their current acute migraine treatment: the Migraine Assessment of Current Therapy (Migraine-ACT) questionnaire [J].

Dowson, AJ ;

Tepper, SJ ;

Baos, V ;

Baudet, F ;

D'Amico, D ;

Kilminster, S .

CURRENT MEDICAL RESEARCH AND OPINION, 2004, 20 (07) :1125-1135

← 1 2 3 4 →